Literature DB >> 20635252

Measuring depression levels in HIV-infected patients as part of routine clinical care using the nine-item Patient Health Questionnaire (PHQ-9).

P K Crane1, L E Gibbons, J H Willig, M J Mugavero, S T Lawrence, J E Schumacher, M S Saag, M M Kitahata, H M Crane.   

Abstract

Little is known about the psychometric properties of depression instruments among persons infected with HIV. We analyzed data from a large sample of patients in usual care in two US cities (n=1467) using the nine-item Patient Health Questionnaire (PHQ-9) from the PRIME-MD. The PHQ-9 had curvilinear scaling properties and varying levels of measurement precision along the continuum of depression measured by the instrument. In our cohort, the scale showed a prominent floor effect and a distribution of scores across depression severity levels. Three items had differential item functioning (DIF) with respect to race (African-American vs. white); two had DIF with respect to sex; and one had DIF with respect to age. There was minimal individual-level DIF impact. Twenty percent of the difference in mean depression levels between African-Americans and whites was due to DIF. While standard scores for the PHQ-9 may be appropriate for use with individual HIV-infected patients in cross-sectional settings, these results suggest that investigations of depression across groups and within patients across time may require a more sophisticated analytic framework.

Entities:  

Mesh:

Year:  2010        PMID: 20635252      PMCID: PMC3410748          DOI: 10.1080/09540120903483034

Source DB:  PubMed          Journal:  AIDS Care        ISSN: 0954-0121


  61 in total

1.  Screening for depression: recommendations and rationale.

Authors: 
Journal:  Ann Intern Med       Date:  2002-05-21       Impact factor: 25.391

2.  Sociodemographic and psychological variables influencing adherence to antiretroviral therapy.

Authors:  V Gordillo; J del Amo; V Soriano; J González-Lahoz
Journal:  AIDS       Date:  1999-09-10       Impact factor: 4.177

3.  Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence.

Authors:  M R DiMatteo; H S Lepper; T W Croghan
Journal:  Arch Intern Med       Date:  2000-07-24

4.  Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire.

Authors:  R L Spitzer; K Kroenke; J B Williams
Journal:  JAMA       Date:  1999-11-10       Impact factor: 56.272

5.  Monitoring depression treatment outcomes with the patient health questionnaire-9.

Authors:  Bernd Löwe; Jürgen Unützer; Christopher M Callahan; Anthony J Perkins; Kurt Kroenke
Journal:  Med Care       Date:  2004-12       Impact factor: 2.983

6.  A prospective trial of sustained-release bupropion for depression in HIV-seropositive and AIDS patients.

Authors:  M Beatriz Currier; German Molina; Martha Kato
Journal:  Psychosomatics       Date:  2003 Mar-Apr       Impact factor: 2.386

7.  Depression and clinical progression in HIV-infected drug users treated with highly active antiretroviral therapy.

Authors:  Anne-Déborah Bouhnik; Marie Préau; Emmanuelle Vincent; Maria Patrizia Carrieri; Hervé Gallais; Gérard Lepeu; Jean-Albert Gastaut; Jean-Paul Moatti; Bruno Spire
Journal:  Antivir Ther       Date:  2005

8.  Citalopram treatment of major depressive disorder in Hispanic HIV and AIDS patients: a prospective study.

Authors:  M Beatriz Currier; German Molina; Martha Kato
Journal:  Psychosomatics       Date:  2004 May-Jun       Impact factor: 2.386

Review 9.  Depression is a risk factor for suboptimal adherence to highly active antiretroviral therapy.

Authors:  Fabrizio Starace; Adriana Ammassari; Maria Paola Trotta; Rita Murri; Patrizio De Longis; Crescenzo Izzo; Alfredo Scalzini; Antonella d'Arminio Monforte; Albert W Wu; Andrea Antinori
Journal:  J Acquir Immune Defic Syndr       Date:  2002-12-15       Impact factor: 3.731

10.  The Alcohol, Smoking and Substance Involvement Screening Test (ASSIST): development, reliability and feasibility.

Authors: 
Journal:  Addiction       Date:  2002-09       Impact factor: 6.526

View more
  34 in total

1.  Challenges in addressing depression in HIV research: assessment, cultural context, and methods.

Authors:  Jane M Simoni; Steven A Safren; Lisa E Manhart; Karen Lyda; Cynthia I Grossman; Deepa Rao; Matthew J Mimiaga; Frank Y Wong; Sheryl L Catz; Michael B Blank; Ralph DiClemente; Ira B Wilson
Journal:  AIDS Behav       Date:  2011-02

2.  Measurement of depression treatment among patients receiving HIV primary care: Whither the truth?

Authors:  Bethany L DiPrete; Brian W Pence; David J Grelotti; Bradley N Gaynes
Journal:  J Affect Disord       Date:  2018-01-03       Impact factor: 4.839

3.  Depression and Anxiety as Risk Factors for Delayed Care-Seeking Behavior in Human Immunodeficiency Virus-Infected Individuals in South Africa.

Authors:  Madhura S Rane; Ting Hong; Sabina Govere; Hilary Thulare; Mahomed-Yunus Moosa; Connie Celum; Paul K Drain
Journal:  Clin Infect Dis       Date:  2018-10-15       Impact factor: 9.079

4.  lordif: An R Package for Detecting Differential Item Functioning Using Iterative Hybrid Ordinal Logistic Regression/Item Response Theory and Monte Carlo Simulations.

Authors:  Seung W Choi; Laura E Gibbons; Paul K Crane
Journal:  J Stat Softw       Date:  2011-03-01       Impact factor: 6.440

5.  Measurement invariance of the patient health questionnaire-9 (PHQ-9) depression screener in U.S. adults across sex, race/ethnicity, and education level: NHANES 2005-2016.

Authors:  Jay S Patel; Youngha Oh; Kevin L Rand; Wei Wu; Melissa A Cyders; Kurt Kroenke; Jesse C Stewart
Journal:  Depress Anxiety       Date:  2019-07-29       Impact factor: 6.505

Review 6.  Modifying measures based on differential item functioning (DIF) impact analyses.

Authors:  Jeanne A Teresi; Mildred Ramirez; Richard N Jones; Seung Choi; Paul K Crane
Journal:  J Aging Health       Date:  2012-03-15

7.  Somatic symptoms and the association between hepatitis C infection and depression in HIV-infected patients.

Authors:  Jeanie C Yoon; Paul K Crane; Paul S Ciechanowski; Robert D Harrington; Mari M Kitahata; Heidi M Crane
Journal:  AIDS Care       Date:  2011-05-23

8.  Brief Report: Reduced Use of Illicit Substances, Even Without Abstinence, Is Associated With Improved Depressive Symptoms Among People Living With HIV.

Authors:  Joseph A Delaney; Robin M Nance; Bridget M Whitney; Frederick L Altice; Xinyuan Dong; Maria Esther Perez Trejo; Mika Matsuzaki; Faye S Taxman; Geetanjali Chander; Irene Kuo; Rob Fredericksen; Lauren N Strand; Joseph J Eron; Elvin Geng; Mari M Kitahata; William C Mathews; Kenneth Mayer; Richard D Moore; Michael S Saag; Sandra Springer; Redonna Chandler; Shoshana Kahana; Heidi M Crane
Journal:  J Acquir Immune Defic Syndr       Date:  2018-11-01       Impact factor: 3.731

9.  Reliability and validity of the Haitian Creole PHQ-9.

Authors:  Linda G Marc; Whitney R Henderson; Astrid Desrosiers; Marcia A Testa; Samuel E Jean; Eniko Edit Akom
Journal:  J Gen Intern Med       Date:  2014-08-05       Impact factor: 5.128

10.  The Depression Treatment Cascade: Disparities by Alcohol Use, Drug Use, and Panic Symptoms Among Patients in Routine HIV Care in the United States.

Authors:  Bethany L DiPrete; Brian W Pence; Angela M Bengtson; Richard D Moore; David J Grelotti; Conall O'Cleirigh; Riddhi Modi; Bradley N Gaynes
Journal:  AIDS Behav       Date:  2019-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.